Endoluminal radiofrequency ablation with SpyGlass™ in the management of cholangiocarcinoma

• Rodrigo Mansilla-Vivar ^[1] ; Lidia Argüello-Viúdez ^[1] ; Cristina Sánchez-Montes ^[1] ; Noelia Alonso-Lázaro ^[1] ; Vicente Pons-Beltrán ^[1]
  1. [1] Hospital Universitario Politécnico La Fe. Valencia, Spain
• Localización: Revista Española de Enfermedades Digestivas, ISSN-e 2340-4167, ISSN 1130-0108, Vol. 111, Nº. 10, 2019, págs. 803-805
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Most extrahepatic cholangiocarcinomas are unresectable at the time of diagnosis and even in case of a resectable cancer, surgery is not an option for the elderly or patients with comorbidities (1). Current treatment alternatives in these scenarios are very limited. Biliary stenting with self-expanding metal stents (SEMS) is the mainstay palliative treatment for biliary obstruction (2). However, emerging experience with endoscopic RF ablation (RFA) in this setting has been reported in the literature.